Dishman Carbogen Amcis Appoints Sandeep Jaiswal as Vice President (International Marketing)
Dishman Carbogen Amcis Limited appointed Sandeep Jaiswal as Vice President (International Marketing) effective April 20, 2026. Jaiswal has 27 years of experience in business development and marketing within the pharmaceutical and chemical sectors.
The appointment of a Vice President for International Marketing is an operational change that is unlikely to have a significant immediate impact on the company's overall financial performance or market position.
The appointment of a new senior management personnel is a routine operational event and does not inherently indicate a positive or negative shift in the company's performance or outlook.
Dishman Carbogen Amcis Limited (DCAL) has announced the appointment of Mr. Sandeep Jaiswal as Vice President (International Marketing). Mr. Jaiswal officially took charge of his new role on 20th April, 2026, following his induction.
His appointment was made in accordance with the company's policy and the criteria approved by the Nomination and Remuneration Committee. Mr. Jaiswal brings extensive experience of 27 years in Business Development, Marketing, and Sales, with a focus on Active Pharmaceutical Ingredients (APIs), Speciality Chemicals, Intermediaries, and Food Activities. He is 51 years old and holds a PGDM in Marketing & International Business, along with a B.Sc. in Chemistry & Botany. Prior to joining DCAL, he served as General Manager – Marketing at Apotex Pharmachem India PVT. LTD.
This disclosure is made pursuant to Regulation 30 read with Schedule III and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
What to do with a filing like this
Dishman Carbogen Amcis Limited filed this with the NSE as a statutory disclosure, categorised under key management changes. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Dishman Carbogen Amcis Limited. Read the original for the full detail.